Giffin Daughtridge, et al. “The Time Is Now for Disruptive Innovation in Pre-Exposure Prophylaxis Adherence Monitoring”. HIV/AIDS/Research/and/Treatment, vol. 7, no. 1, July 2020, pp. 5-9, doi:10.17140/HARTOJ-7-133.